Millepertuis capsule
Natural health product licensed in Canada
- Licence holder
- Clef des Champs Inc.
- NPN or DIN-HM
- 80144179
- Status
- Active licence
- Licence date
- 17 September 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Hypericum perforatum | 300 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 5 Capsule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Utilisé (traditionnellement) en phytothérapie pour aider à soulager l'agitation et/ou la nervosité (nervin/calmant).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Cessez l'utilisation et consultez un praticien de soins de santé/fournisseur de soins de santé/professionnel de la santé/médecin/docteur si vous ressentez des contractions musculaires ou rigidité, tremblements, agitation/confusion, accélération du rythme cardiaque ou hypersensibilité/allergie. Lorsque vous utilisez ce produit, vous pourriez souffrir de troubles gastro-intestinaux bénins, d'agitation et/ou de maux de tête.
Source
Official Health Canada record, licence 80144179
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.